Amgen | AMGN - Cost Of Sales

Stock Price
325.05
Daily Change
-21.20 -6.12%
Monthly
-6.58%
Yearly
15.59%
Q2 Forecast
337.18

Amgen reported $1.6B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AbbVie USD 4.22B 329M Mar/2026
Agios Pharmaceuticals USD 1.32M 560K Mar/2026
ALKERMES USD 46.21M 5.38M Dec/2025
Amgen USD 1.6B 187M Mar/2026
Biogen USD 797.5M 302M Mar/2026
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Coherus Biosciences USD 4.04M 324K Dec/2025
Eli Lilly USD 3.58B 205M Mar/2026
Exelixis USD 26.48M 7.91M Dec/2025
Genmab DKK 81M 23M Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Glaxosmithkline GBP 3.47B 461.37M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
J&J USD 8.07B 103M Mar/2026
Merck USD 2.94B 380M Mar/2026
Moderna USD 955M 503M Mar/2026
Neurocrine Biosciences USD 17.6M 246.4M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Novartis USD 3.54B 7M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
PTC Therapeutics USD 16.3M 7.02M Dec/2025
Puma Biotechnology USD 29.1M 18.44M Sep/2024
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Sarepta Therapeutics USD 399.38M 247.93M Dec/2025
Takeda JPY 401.15B 184.07B Dec/2025
Teva Pharmaceutical Industries USD 2.01B 46M Mar/2026
Ultragenyx Pharmaceutical USD 29M 1.01M Dec/2025
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025